secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2024-10-23T23:59:59+00:00
Accession:  0001493152-24-042172
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology gets Nasdaq extension to Feb 18, 2025 to meet equity requirement
--------------------------------------------------------------------------------

- Nasdaq notified non-compliance with $2.5M minimum stockholders' equity requirement.
- Company submitted compliance plan; Nasdaq granted extension until February 18, 2025.
- Filed S-1 registration statement to raise up to $4.0M in equity capital.
- Failure to evidence compliance by March 31, 2025 may lead to delisting.
- Common stock and warrants continue trading on Nasdaq under LIXT and LIXTW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224042172/0001493152-24-042172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224042172/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer